The Association between Type 2 Diabetes Mellitus and Thyroid Cancer

Aim. The incidence of thyroid cancer is increasing worldwide. The prevalence of type 2 diabetes mellitus (T2DM) is also increasing. Therefore, we aimed to analyze the effect of T2DM on thyroid cancer. Methods. A case-control study was performed. A total of 415 healthy controls with thyroid ultrasoun...

Full description

Saved in:
Bibliographic Details
Main Authors: Young-Gyun Seo, Ho-Chun Choi, Ah Reum An, Do Joon Park, Young Joo Park, Kyu Eun Lee, Sue K. Park, Yunji Hwang, Belong Cho
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2017/5850879
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559325713793024
author Young-Gyun Seo
Ho-Chun Choi
Ah Reum An
Do Joon Park
Young Joo Park
Kyu Eun Lee
Sue K. Park
Yunji Hwang
Belong Cho
author_facet Young-Gyun Seo
Ho-Chun Choi
Ah Reum An
Do Joon Park
Young Joo Park
Kyu Eun Lee
Sue K. Park
Yunji Hwang
Belong Cho
author_sort Young-Gyun Seo
collection DOAJ
description Aim. The incidence of thyroid cancer is increasing worldwide. The prevalence of type 2 diabetes mellitus (T2DM) is also increasing. Therefore, we aimed to analyze the effect of T2DM on thyroid cancer. Methods. A case-control study was performed. A total of 415 healthy controls with thyroid ultrasound screening and physician consultation were selected from the Thyroid Cancer Longitudinal Study (T-CALOS). Among patients with thyroid cancer who were enrolled in T-CALOS, 415 patients were matched to the control group according to age and sex. We assessed the effects of T2DM, T2DM duration, and T2DM medication on thyroid cancer. Results. Women with T2DM had lower odds of thyroid cancer than women without T2DM (odds ratio [OR]: 0.40, 95% confidence interval [CI]: 0.20–0.81). Individuals receiving T2DM medication had higher odds of thyroid cancer compared to those without T2DM medication (OR: 5.21, 95% CI: 1.58–17.15). Individuals with T2DM duration <6 years had lower odds of thyroid cancer compared to those without T2DM (OR: 0.58, 95% CI: 0.34–0.97). Conclusions. Individuals with early T2DM are presumed to have a low incidence of thyroid cancer, and this effect seems to last up to 6 years after diagnosis of T2DM.
format Article
id doaj-art-08b8d57ce8c448c18cdd45f7b217da1d
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-08b8d57ce8c448c18cdd45f7b217da1d2025-02-03T01:30:13ZengWileyJournal of Diabetes Research2314-67452314-67532017-01-01201710.1155/2017/58508795850879The Association between Type 2 Diabetes Mellitus and Thyroid CancerYoung-Gyun Seo0Ho-Chun Choi1Ah Reum An2Do Joon Park3Young Joo Park4Kyu Eun Lee5Sue K. Park6Yunji Hwang7Belong Cho8Department of Family Medicine, Hallym University Sacred Heart Hospital, Anyang, Gyeonggi-do 14068, Republic of KoreaDepartment of Family Medicine, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul 03080, Republic of KoreaDepartment of Family Medicine, Center for Health Promotion and Optimal Aging, Health Promotion Center for Cancer Survivor, Seoul National University Hospital, Seoul 03080, Republic of KoreaDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of KoreaDepartment of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of KoreaDepartment of Surgery, Seoul National University Hospital & College of Medicine, Seoul 03080, Republic of KoreaDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of KoreaDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of KoreaDepartment of Family Medicine, Center for Health Promotion and Optimal Aging, Health Promotion Center for Cancer Survivor, Seoul National University Hospital, Seoul 03080, Republic of KoreaAim. The incidence of thyroid cancer is increasing worldwide. The prevalence of type 2 diabetes mellitus (T2DM) is also increasing. Therefore, we aimed to analyze the effect of T2DM on thyroid cancer. Methods. A case-control study was performed. A total of 415 healthy controls with thyroid ultrasound screening and physician consultation were selected from the Thyroid Cancer Longitudinal Study (T-CALOS). Among patients with thyroid cancer who were enrolled in T-CALOS, 415 patients were matched to the control group according to age and sex. We assessed the effects of T2DM, T2DM duration, and T2DM medication on thyroid cancer. Results. Women with T2DM had lower odds of thyroid cancer than women without T2DM (odds ratio [OR]: 0.40, 95% confidence interval [CI]: 0.20–0.81). Individuals receiving T2DM medication had higher odds of thyroid cancer compared to those without T2DM medication (OR: 5.21, 95% CI: 1.58–17.15). Individuals with T2DM duration <6 years had lower odds of thyroid cancer compared to those without T2DM (OR: 0.58, 95% CI: 0.34–0.97). Conclusions. Individuals with early T2DM are presumed to have a low incidence of thyroid cancer, and this effect seems to last up to 6 years after diagnosis of T2DM.http://dx.doi.org/10.1155/2017/5850879
spellingShingle Young-Gyun Seo
Ho-Chun Choi
Ah Reum An
Do Joon Park
Young Joo Park
Kyu Eun Lee
Sue K. Park
Yunji Hwang
Belong Cho
The Association between Type 2 Diabetes Mellitus and Thyroid Cancer
Journal of Diabetes Research
title The Association between Type 2 Diabetes Mellitus and Thyroid Cancer
title_full The Association between Type 2 Diabetes Mellitus and Thyroid Cancer
title_fullStr The Association between Type 2 Diabetes Mellitus and Thyroid Cancer
title_full_unstemmed The Association between Type 2 Diabetes Mellitus and Thyroid Cancer
title_short The Association between Type 2 Diabetes Mellitus and Thyroid Cancer
title_sort association between type 2 diabetes mellitus and thyroid cancer
url http://dx.doi.org/10.1155/2017/5850879
work_keys_str_mv AT younggyunseo theassociationbetweentype2diabetesmellitusandthyroidcancer
AT hochunchoi theassociationbetweentype2diabetesmellitusandthyroidcancer
AT ahreuman theassociationbetweentype2diabetesmellitusandthyroidcancer
AT dojoonpark theassociationbetweentype2diabetesmellitusandthyroidcancer
AT youngjoopark theassociationbetweentype2diabetesmellitusandthyroidcancer
AT kyueunlee theassociationbetweentype2diabetesmellitusandthyroidcancer
AT suekpark theassociationbetweentype2diabetesmellitusandthyroidcancer
AT yunjihwang theassociationbetweentype2diabetesmellitusandthyroidcancer
AT belongcho theassociationbetweentype2diabetesmellitusandthyroidcancer
AT younggyunseo associationbetweentype2diabetesmellitusandthyroidcancer
AT hochunchoi associationbetweentype2diabetesmellitusandthyroidcancer
AT ahreuman associationbetweentype2diabetesmellitusandthyroidcancer
AT dojoonpark associationbetweentype2diabetesmellitusandthyroidcancer
AT youngjoopark associationbetweentype2diabetesmellitusandthyroidcancer
AT kyueunlee associationbetweentype2diabetesmellitusandthyroidcancer
AT suekpark associationbetweentype2diabetesmellitusandthyroidcancer
AT yunjihwang associationbetweentype2diabetesmellitusandthyroidcancer
AT belongcho associationbetweentype2diabetesmellitusandthyroidcancer